Featured
-
-
Article
| Open Access
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin
- Mikael Lisak
- , Malin Nicklasson
- & Markus Hansson
-
Article
| Open Access
Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells
- Kristen S. Hill
- , Erin E. Schuler
- & Jill M. Kolesar
-
Article
| Open Access
Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy
- Lukasz Bolkun
- , Tomasz Pienkowski
- & Michal Ciborowski
-
Article
| Open Access
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
- Paul Jäger
- , Christina Rautenberg
- & Guido Kobbe
-
Article
| Open Access
Detection of acute promyelocytic leukemia in peripheral blood and bone marrow with annotation-free deep learning
- Petru Manescu
- , Priya Narayanan
- & Delmiro Fernandez-Reyes
-
Article
| Open Access
Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders
- Rika Kanezaki
- , Tsutomu Toki
- & Etsuro Ito
-
Article
| Open Access
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia
- Maddalena Marconato
- , Joseph Kauer
- & Jonas S. Heitmann
-
Article
| Open Access
Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis
- Barbara Tomic
- , Tomislav Smoljo
- & Dora Visnjic
-
Article
| Open Access
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML
- Emmanuel Gyan
- , Arnaud Pigneux
- & Olivier Hérault
-
Article
| Open Access
High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
- Hajime Senjo
- , Masahiro Onozawa
- & Takanori Teshima
-
Article
| Open Access
scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs
- Kooper V. Hunt
- , Sean M. Burnard
- & Heather J. Lee
-
Article
| Open Access
Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
- Justine Klosner
- , Konstantin Agelopoulos
- & Carsten Müller-Tidow
-
Article
| Open AccessIncidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
- Sang-Min Oh
- , Ja Min Byun
- & Myoung-don Oh
-
Article
| Open Access
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
- Meike Farber
- , Yiyang Chen
- & Maher Hanoun
-
Article
| Open Access
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18
- Michael Maher
- , Jeannine Diesch
- & Marcus Buschbeck
-
Article
| Open Access
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
- Tamara Castaño-Bonilla
- , Juan M. Alonso-Dominguez
- & Pau Montesinos
-
Article
| Open Access
Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells
- Yasaman KalantarMotamedi
- , Fatemeh Ejeian
- & Andreas Bender
-
Article
| Open Access
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
- Marta Libura
- , Emilia Bialopiotrowicz
- & Olga Haus
-
Article
| Open Access
(–)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1
- Fernanda Isabel Della Via
- , Rodrigo Naoto Shiraishi
- & Cristiane Okuda Torello
-
Article
| Open Access
Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia
- Binglei Zhang
- , Lingyun Chen
- & Yongping Song
-
Article
| Open Access
The factors influencing clinical outcomes after leukapheresis in acute leukaemia
- Howon Lee
- , Silvia Park
- & Yonggoo Kim
-
Article
| Open Access
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
- Julia M. Kempf
- , Sabrina Weser
- & Karsten Spiekermann
-
Article
| Open Access
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
- Feng-Ting Dao
- , Jun Wang
- & Ya-Zhen Qin
-
Article
| Open Access
Occupational pesticide exposure increases risk of acute myeloid leukemia: a meta-analysis of case–control studies including 3,955 cases and 9,948 controls
- Amelie Foucault
- , Nicolas Vallet
- & Olivier Herault
-
Article
| Open Access
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells
- Mina Noura
- , Ken Morita
- & Souichi Adachi
-
Article
| Open Access
A novel nutritional index “simplified CONUT” and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia
- Hajime Senjo
- , Masahiro Onozawa
- & Takanori Teshima
-
Article
| Open Access
Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
- G. D. Bailey
- , L. Doolan
- & C. H. Seedhouse
-
Article
| Open Access
Long-term in vivo imaging reveals tumor-specific dissemination and captures host tumor interaction in zebrafish xenografts
- Nandini Asokan
- , Stephan Daetwyler
- & Martin Bornhäuser
-
Article
| Open Access
Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients
- Chris Lauber
- , Nádia Correia
- & Michael Seifert
-
Article
| Open Access
Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia
- Hetty E. Carraway
- , Sridhar A. Malkaram
- & Tamer E. Fandy
-
Article
| Open Access
NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia
- Carolina Hassibe Thomé
- , Germano Aguiar Ferreira
- & Eduardo M. Rego
-
Article
| Open Access
ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia
- Michal Hayun
- , Maria Zaatra
- & Yishai Ofran
-
Article
| Open Access
Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype
- Mariam Ibáñez
- , Esperanza Such
- & José Cervera
-
Article
| Open Access
High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia
- C. Ward
- , P. Cauchy
- & G. Volpe
-
Article
| Open Access
Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors
- S. Greg Call
- , Ryan P. Duren
- & Orla M. Conneely
-
Article
| Open Access
Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia
- Jingyi Wang
- , Na He
- & Daoxin Ma
-
Article
| Open Access
STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia
- Gabrielle Sueur
- , Alison Boutet
- & Sarah Bertoli
-
Article
| Open Access
Clinical heterogeneity under induction with different dosages of cytarabine in core binding factor acute myeloid leukaemia
- Biao Wang
- , Jihong Zhang
- & Bin Yang
-
Article
| Open Access
The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein
- Lu Cao
- , Partha Mitra
- & Thomas J. Gonda
-
Article
| Open Access
CD105 (Endoglin) as negative prognostic factor in AML
- Joseph Kauer
- , Karolin Schwartz
- & Melanie Märklin
-
Article
| Open Access
Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice
- Subhadip Kundu
- , Eun Sil Park
- & Peter D. Aplan
-
Article
| Open Access
Multi-study reanalysis of 2,213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures
- Raeuf Roushangar
- & George I. Mias
-
Article
| Open Access
Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells
- Juan Bautista Menendez-Gonzalez
- , Samantha Sinnadurai
- & Neil P. Rodrigues
-
Article
| Open Access
The FLT3-ITD mutation and the expression of its downstream signaling intermediates STAT5 and Pim-1 are positively correlated with CXCR4 expression in patients with acute myeloid leukemia
- Tingyong Cao
- , Nenggang Jiang
- & Qin Zheng
-
Article
| Open Access
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia
- Jae-Ho Yoon
- , Hee-Je Kim
- & Jong Wook Lee
-
Article
| Open Access
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia
- Aarif M. N. Batcha
- , Stefanos A. Bamopoulos
- & Tobias Herold
-
Article
| Open Access
Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells
- Thomas T. Huynh
- , Mohammad Sultan
- & Paola Marcato
-
Article
| Open Access
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
- Chi Huu Nguyen
- , Tobias Glüxam
- & Gerwin Heller
-
Article
| Open Access
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
- Yacong An
- , Yan Hu
- & Xian-Da Yang
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia